WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹26 Cr | ₹14 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹26 Cr |
Mar2024 | ₹14 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-29 Cr |
Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹26 Cr | 85.50 | |
Mar2024 | ₹14 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-29 Cr | Negative | |
Mar2021 | ₹-17 Cr | - |
Compare Cash Flow from Financing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹886.5 Cr | 2.7% | -9.6% | -8.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,063.0 Cr | 3% | 3.5% | -15.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,749.0 Cr | 3.1% | -4.8% | 4.9% | Stock Analytics | |
CIPLA | ₹122,429.0 Cr | 1.1% | -4% | -8.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,928.0 Cr | -1.4% | -2.6% | 4.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,168.0 Cr | -0.4% | -1.1% | -7.8% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 2.7% |
-9.6% |
-8.7% |
SENSEX | 0.1% |
1.3% |
-5.1% |
You may also like the below Video Courses